Valuation: Procter & Gamble Health Limited

Market Cap 94.48B 1.01B 904M 833M 756M 1.43B 1.47B 9.97B 3.97B 50.62B 3.78B 3.7B 160B P/E 2027 *
25.7x
P/E 2028 * 23.1x
Enterprise Value 94.48B 1.01B 904M 833M 756M 1.43B 1.47B 9.97B 3.97B 50.62B 3.78B 3.7B 160B EV / Sales 2027 *
6.11x
EV / Sales 2028 * 5.42x
Free-Float
47.81%
Yield 2027 *
1.91%
Yield 2028 * 2.07%
1 day+1.87%
1 week+1.57%
Current month+2.00%
1 month+11.59%
3 months-3.85%
6 months+10.03%
Current year+1.70%
1 week 5,490
Extreme 5490
5,822
1 month 4,728.3
Extreme 4728.3
6,000
Current year 4,699.7
Extreme 4699.7
6,955
1 year 4,699.7
Extreme 4699.7
6,955
3 years 4,640.3
Extreme 4640.3
6,955
5 years 3,883
Extreme 3883
6,955
10 years 840.7
Extreme 840.7
7,499.95
Manager TitleAgeSince
Chief Executive Officer 57 2018-03-31
Director of Finance/CFO - 2025-09-30
Chief Tech/Sci/R&D Officer - 2025-08-31
Director TitleAgeSince
Director/Board Member 57 2018-03-31
Director/Board Member 51 2019-05-31
Chairman 70 2025-03-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.87%+1.57%-2.49%+11.59% 1.01B
+1.44%+1.63%+48.17%+139.63% 1,276B
-0.47%+5.49%+49.03%+90.68% 676B
+0.20%+2.76%+34.37%+112.06% 519B
-0.66%+0.91%+38.38%+67.33% 388B
-0.48%+2.34%+70.66%+46.02% 365B
-1.03%-0.76%+28.02%+57.46% 307B
-0.17%-1.03%+3.07%+35.44% 287B
0.00%+0.86%+43.74%+74.04% 252B
+0.92%+2.03%+44.62%+125.07% 212B
Average -0.20%+1.89%+35.76%+75.93% 428B
Weighted average by Cap. -0.62%+2.51%+42.75%+96.55%

Financials

2027 *2028 *
Net sales 15.47B 165M 148M 136M 124M 234M 241M 1.63B 651M 8.29B 619M 606M 26.21B 17.43B 186M 167M 154M 140M 264M 272M 1.84B 733M 9.34B 698M 683M 29.53B
Net income 3.67B 39.16M 35.12M 32.36M 29.39M 55.63M 57.18M 388M 154M 1.97B 147M 144M 6.22B 4.09B 43.59M 39.09M 36.03M 32.72M 61.92M 63.65M 431M 172M 2.19B 164M 160M 6.92B
Net Debt - -
Projected Income Statement - Annual - Procter & Gamble Health Limited
Logo Procter & Gamble Health Limited
Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
Employees
1,276
Date Price Change Volume
26-11-11 ₹5,797.90 +1.87% 194
26-11-09 ₹5,691.65 -0.32% 201
26-11-08 ₹5,709.90 +2.97% 150
26-11-06 ₹5,545.00 -1.04% 348
26-11-05 ₹5,603.30 -1.84% 414
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
MarketScreener Ratings - Procter & Gamble Health Limited

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Procter & Gamble Health Limited
  1. Stock Market
  2. Stocks
  3. PGHL Stock